Thursday, April 30, 2015
Prostate Cancer Treatment Market To Grow To $8.2 Billion
… in the treatment of hormone-sensitive prostate cancer.
Furthermore, Raksha Mudbhary, Ph.D … for the treatment of castration-resistant prostate cancer (CRPC).
However, the analyst notes … CRPC, non-metastatic CRPC and hormone-sensitive prostate cancer.
Mudbhary explains: “Xtandi’s safety …
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment